A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson’s Disease

BACKGROUND: Cognitive impairment is common in Parkinson’s disease (PD). There is a critical need for a brief, standard cognitive screening measure for use in PD trials whose primary focus is not on cognition. METHODS: The Parkinson Study Group (PSG) Cognitive/Psychiatric Working Group formed a Task...

Full description

Saved in:
Bibliographic Details
Main Authors: Chou, Kelvin L., Amick, Melissa M., Brandt, Jason, Camicioli, Richard, Frei, Karen, Gitelman, Darren, Goldman, Jennifer, Growdon, John, Hurtig, Howard I., Levin, Bonnie, Litvan, Irene, Marsh, Laura, Simuni, Tanya, Tröster, Alexander I., Uc, Ergun Y.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2978783/
https://ncbi.nlm.nih.gov/pubmed/20878991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.23362
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items